Bibliographic information
GuidelineUpdated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV
Year of Publication2018
Issuing InstitutionWHO
Recommendation
Maintained
Originally developed
Adults and adolescents. When available, atazanavir/r (ATV/r), darunavir/r (DRV/r), lopinavir/r (LPV/r) and RAL may be considered as alternative third drug options for post-exposure prophylaxis
Recommended in favor
Conditional
Certainty of evidence
Low
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year2021
InstitutionWHO
Guideline
Guidelines for HIV post-exposure prophylaxis
Year2025
InstitutionWorld Health Organization